Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 82 for

Edit search filters
  1. A Trial Of The FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered As Maintenance Therapy Following Allogeneic Transplant For Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Rituximab With Or Without Stem Cell Transplant In Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma In First Complete Remission

    Jacksonville, FL, Rochester, MN

  3. A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation

    Jacksonville, FL

  4. A Study Of Ruxolitinib For The Treatment Of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

    Rochester, MN

  5. Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study Of Autologous MSC-NTF Cells In Patients With ALS

    Rochester, MN

  6. Coping With Hematopoietic Stem Cell Transplantation And Psychosocial

    Scottsdale/Phoenix, AZ

  7. A Study Of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy In Patients With Multiple Myeloma Following Autologous Stem Cell Transplant

    Rochester, MN

  8. Evaluation Of The AMICUS Extracorporeal Photopheresis (ECP) System In Patients With Chronic Graft Versus Host Disease

    Rochester, MN

  9. A Study To Evaluate Clinical Transplant-Related Long-term Outcomes Of Alternative Donor Allogeneic Transplantation

    Rochester, MN

  10. Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant To Dara-VCD Chemotherapy Alone For People Who Have Newly Diagnosed AL Amyloidosis

    Rochester, MN

.

Mayo Clinic Footer